FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4322774327> ?p ?o ?g. }

• W4322774327 endingPage "03" @default.
• W4322774327 startingPage "P2" @default.
• W4322774327 abstract "Abstract Background Conventional pathologic scoring of HER2 by IHC is proven to distinguish potential responders to trastuzumab but has not been effective for next generation antibody drug conjugates (ADCs) such as trastuzumab deruxtecan (T-DXd), which is capable of bystander killing. Several alternative approaches have been deployed to measure HER2, including immunofluorescence and mRNA sequencing. We have developed a novel and fully automated computational pathology technique, Quantitative Continuous Scoring (QCS), to quantify the level and distribution of HER2 from digitized HER2 IHC slides in an objective, quantifiable, and reproducible manner on a per-cell basis [Gustavson et al., SABCS 2020]. To further validate this approach, we performed a systematic multi-omic comparison of QCS to orthogonal methods of HER2 quantitation on a cohort of primary and metastatic breast cancer cases (N=30). Methods HER2 was evaluated using three independent methods on serial tissue sections obtained from 30 archival FFPE breast cancer samples distributed over the full range of HER2 expression, from 0 to 3+. HER2-IHC staining (clone 4B5, Roche Tissue Diagnostics) was performed using standard methods and cases were scored by two pathologists using CAP/ASCO guidelines and H-scores were assigned. We performed FISH (HER2 IQFISH pharmDx [Dako]; PathVysion HER-2 DNA Probe Kit [Vysis]), mRNA quantification of ERBB2 transcript levels (Nano String), and immunofluorescence (IF; HER2 clone 29D8, CST). Imaged with Vectra (Akoya) and analyzed with Halo (Indica). QCS readouts were generated from the above-mentioned digital images of IHC slides by using a fully automated image analysis pipeline; readouts included per-cell staining intensity measurements of membranes and cytoplasmic sub-compartments in terms of optical density (OD) [Van der Laak, JQCS 2000], which were aggregated to a single slide-level score. Additionally, using the OD measurements and the cell locations, a Spatial Proximity Score (SPS) was computed, summing the percentage of cells with OD≥10 (corresponding to the limit of visual detection of IHC staining) as well as the percentage of cells with OD&lt; 10 within a prespecified radius (25µm) of a neighboring cell with OD≥10. Results Our analysis demonstrated that QCS-based scoring correlates with orthogonal measurements used in this study. Comparing protein-based assays, the observed Pearson correlation was R=0.88 between QCS median membrane OD and IHC H-scores, R=0.86 with IF-based HER2 mean cell expression intensity, and R=0.85 with IF-based H-scores. Correlation with transcriptomic profiling was R=0.81 for OD vs. mRNA, however ERBB2 transcript levels did not distinguish between HER2 0, 1+, and 2+ FISH negative cases, while QCS was able to do so. Correlation between protein-based and nucleic-acid based assays were numerically worse, with R=0.64 for OD vs. FISH. All samples (including those with HER2 IHC scores of 0 and H-Scores &lt; 10) had at least ~20% of cells with quantifiable HER2 expression by OD, the presence of which was confirmed using IF. For cases in the lowest quartile of HER2 expression by OD, SPS identified 20-50% additional HER2-null cells that were in close proximity to HER2-expressing cells that may be vulnerable to bystander killing. Conclusion QCS-based scoring is consistent with orthogonal protein-based measurements across the range of HER2 expression. Most importantly, QCS derived-spatial analysis features identify additional patients in the lower end of HER2 expression that might be highly relevant for ADC response prediction, particularly if a drug exerts bystander activity. Further clinical verification and validation on large cohorts is needed. Footnote: This study was approved by the IRB at MSKCC. Citation Format: Joshua Drago, Zonera Hassan, Jan Zaucha, Ansh Kapil, Fatemeh Derakhshan, Fresia Pareja, Shimulov Anatoliy, Fanni Ratzon, Travis J Hollman, Claire Myers, Jessica Chan, Andrea Spitzmuller, Mark Gustavson, Danielle Carroll, Dara Ross, Jorge Reis-Filho, Carl barrett, Sihem Khalifa, Schmidt Guenter, Hadassah Sade, Sarat Chandarlapaty. Quantification of HER2 expression and spatial biology using computational pathology: A cross-assay validation study in breast cancer [abstract]. In: Proceedings of the 2022 San Antonio Breast Cancer Symposium; 2022 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2023;83(5 Suppl):Abstract nr P2-09-03." @default.
• W4322774327 created "2023-03-03" @default.
• W4322774327 creator A5003635959 @default.
• W4322774327 creator A5006705594 @default.
• W4322774327 creator A5010677416 @default.
• W4322774327 creator A5012686198 @default.
• W4322774327 creator A5013126737 @default.
• W4322774327 creator A5013266635 @default.
• W4322774327 creator A5014716846 @default.
• W4322774327 creator A5017293859 @default.
• W4322774327 creator A5023176468 @default.
• W4322774327 creator A5030160451 @default.
• W4322774327 creator A5038307722 @default.
• W4322774327 creator A5039203448 @default.
• W4322774327 creator A5041961484 @default.
• W4322774327 creator A5044987792 @default.
• W4322774327 creator A5046909219 @default.
• W4322774327 creator A5047094787 @default.
• W4322774327 creator A5062874387 @default.
• W4322774327 creator A5072922624 @default.
• W4322774327 creator A5077235697 @default.
• W4322774327 creator A5088339499 @default.
• W4322774327 creator A5089149851 @default.
• W4322774327 date "2023-03-01" @default.
• W4322774327 modified "2023-09-27" @default.
• W4322774327 title "Abstract P2-09-03: Quantification of HER2 expression and spatial biology using computational pathology: A cross-assay validation study in breast cancer" @default.
• W4322774327 doi "https://doi.org/10.1158/1538-7445.sabcs22-p2-09-03" @default.
• W4322774327 hasPublicationYear "2023" @default.
• W4322774327 type Work @default.
• W4322774327 citedByCount "0" @default.
• W4322774327 crossrefType "journal-article" @default.
• W4322774327 hasAuthorship W4322774327A5003635959 @default.
• W4322774327 hasAuthorship W4322774327A5006705594 @default.
• W4322774327 hasAuthorship W4322774327A5010677416 @default.
• W4322774327 hasAuthorship W4322774327A5012686198 @default.
• W4322774327 hasAuthorship W4322774327A5013126737 @default.
• W4322774327 hasAuthorship W4322774327A5013266635 @default.
• W4322774327 hasAuthorship W4322774327A5014716846 @default.
• W4322774327 hasAuthorship W4322774327A5017293859 @default.
• W4322774327 hasAuthorship W4322774327A5023176468 @default.
• W4322774327 hasAuthorship W4322774327A5030160451 @default.
• W4322774327 hasAuthorship W4322774327A5038307722 @default.
• W4322774327 hasAuthorship W4322774327A5039203448 @default.
• W4322774327 hasAuthorship W4322774327A5041961484 @default.
• W4322774327 hasAuthorship W4322774327A5044987792 @default.
• W4322774327 hasAuthorship W4322774327A5046909219 @default.
• W4322774327 hasAuthorship W4322774327A5047094787 @default.
• W4322774327 hasAuthorship W4322774327A5062874387 @default.
• W4322774327 hasAuthorship W4322774327A5072922624 @default.
• W4322774327 hasAuthorship W4322774327A5077235697 @default.
• W4322774327 hasAuthorship W4322774327A5088339499 @default.
• W4322774327 hasAuthorship W4322774327A5089149851 @default.
• W4322774327 hasConcept C121608353 @default.
• W4322774327 hasConcept C126322002 @default.
• W4322774327 hasConcept C142724271 @default.
• W4322774327 hasConcept C143998085 @default.
• W4322774327 hasConcept C159654299 @default.
• W4322774327 hasConcept C203014093 @default.
• W4322774327 hasConcept C204232928 @default.
• W4322774327 hasConcept C2778236600 @default.
• W4322774327 hasConcept C2779786085 @default.
• W4322774327 hasConcept C2780416959 @default.
• W4322774327 hasConcept C530470458 @default.
• W4322774327 hasConcept C71924100 @default.
• W4322774327 hasConceptScore W4322774327C121608353 @default.
• W4322774327 hasConceptScore W4322774327C126322002 @default.
• W4322774327 hasConceptScore W4322774327C142724271 @default.
• W4322774327 hasConceptScore W4322774327C143998085 @default.
• W4322774327 hasConceptScore W4322774327C159654299 @default.
• W4322774327 hasConceptScore W4322774327C203014093 @default.
• W4322774327 hasConceptScore W4322774327C204232928 @default.
• W4322774327 hasConceptScore W4322774327C2778236600 @default.
• W4322774327 hasConceptScore W4322774327C2779786085 @default.
• W4322774327 hasConceptScore W4322774327C2780416959 @default.
• W4322774327 hasConceptScore W4322774327C530470458 @default.
• W4322774327 hasConceptScore W4322774327C71924100 @default.
• W4322774327 hasIssue "5_Supplement" @default.
• W4322774327 hasLocation W43227743271 @default.
• W4322774327 hasOpenAccess W4322774327 @default.
• W4322774327 hasPrimaryLocation W43227743271 @default.
• W4322774327 hasRelatedWork W1722328147 @default.
• W4322774327 hasRelatedWork W2066747782 @default.
• W4322774327 hasRelatedWork W2443284480 @default.
• W4322774327 hasRelatedWork W2560406314 @default.
• W4322774327 hasRelatedWork W2627001382 @default.
• W4322774327 hasRelatedWork W2751941543 @default.
• W4322774327 hasRelatedWork W2896532861 @default.
• W4322774327 hasRelatedWork W2934076975 @default.
• W4322774327 hasRelatedWork W75229661 @default.
• W4322774327 hasRelatedWork W2342209702 @default.
• W4322774327 hasVolume "83" @default.
• W4322774327 isParatext "false" @default.
• W4322774327 isRetracted "false" @default.
• W4322774327 workType "article" @default.